Sanofi’s new CEO Belén Garijo gets frosty reception as challenges awaitnews2026-02-12T16:49:55+00:00February 12th, 2026|Endpoints News|
UK attractive for investment, Fujifilm CEO says; Moderna’s Mexico dealnews2026-02-12T16:26:00+00:00February 12th, 2026|Endpoints News|
Controversy around FDA’s Prasad rises again after Moderna rejection, behavior allegationsnews2026-02-12T16:24:16+00:00February 12th, 2026|Endpoints News|
How employers feel about the state of healthcare (and GLP-1s)news2026-02-12T16:07:36+00:00February 12th, 2026|Endpoints News|
A pancreatic cancer approval; Seres cuts staffnews2026-02-12T15:10:19+00:00February 12th, 2026|Endpoints News|
Even Europeans don’t see a future in Euro biopharma anymorenews2026-02-12T14:27:08+00:00February 12th, 2026|Endpoints News|
Terray says its AI model beats Boltz-2 at binding affinity predictionnews2026-02-12T13:00:16+00:00February 12th, 2026|Endpoints News|
Lyell starts first head-to-head CAR-T therapy trialnews2026-02-12T12:35:01+00:00February 12th, 2026|Endpoints News|
BridgeBio’s dwarfism drug succeeds in Phase 3, adding to recent late-stage winsnews2026-02-12T12:30:41+00:00February 12th, 2026|Endpoints News|
Leash Bio warns of ‘cheating’ AI models on drug-protein predictionsnews2026-02-12T12:00:17+00:00February 12th, 2026|Endpoints News|
